CDKN2A and acute lymphoblastic leukemia: However, the likely causal variants have only been identified through comprehensive fine-mapping and functional experimental analyses at four ALL risk loci (ARID5B, CDKN2A, GATA3, and IKFZF1) (84, 110, 111, 112).